1
|
Neubauer C, Yilmaz JS, Bronsert P, Pichotka M, Bamberg F, Windfuhr-Blum M, Erbes T, Neubauer J. Accuracy of cone-beam computed tomography, digital mammography and digital breast tomosynthesis for microcalcifications and margins to microcalcifications in breast specimens. Sci Rep 2022; 12:17639. [PMID: 36271228 PMCID: PMC9587219 DOI: 10.1038/s41598-022-21616-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2022] [Accepted: 09/29/2022] [Indexed: 01/18/2023] Open
Abstract
Accurate determination of resection margins in breast specimens is important as complete removal of malignancy is a prerequisite for patients' outcome. Mammography (DM) as 2D-technique provides only limited value in margin assessment. Therefore, we investigated whether cone-beam computed tomography (CBCT) or digital breast tomosynthesis (DBT) has incremental value in assessing margins to microcalcifications. Three independent readers investigated breast specimens for presence of microcalcifications and the smallest distance to margins. Histopathology served as gold standard. Microcalcifications were detected in 15 out of 21 included specimens (71%). Pooled sensitivity for DM, DBT and CBCT for microcalcifications compared to preoperative DM was 0.98 (CI 0.94-0.99), 0.83 (CI 0.73-0.94) and 0.94 (CI 0.87-0.99), pooled specificity was 0.99 (CI 0.99-0.99), 0.73 (CI 0.51-0.96) and 0.60 (CI 0.35-0.85). Mean measurement error for margin determination for DM, DBT and CBCT was 10 mm, 14 mm and 6 mm (p = 0.002) with significant difference between CBCT and the other devices (p < 0.03). Mean reading time required by the readers to analyze DM, DBT and CBCT, was 36, 43 and 54 s (p < 0.001). Although DM allows reliable detection of microcalcifications, measurement of resection margin was significantly more accurate with CBCT. Thus, a combination of methods or improved CBCT might provide a more accurate determination of disease-free margins in breast specimens.
Collapse
Affiliation(s)
- Claudia Neubauer
- grid.5963.9Department of Radiology, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany
| | - Jannina Samantha Yilmaz
- grid.5963.9Department of Radiology, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany
| | - Peter Bronsert
- grid.5963.9Institute for Surgical Pathology, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany ,grid.5963.9Tumorbank Comprehensive Cancer Center Freiburg, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg Im Breisgau, Germany ,grid.5963.9Core Facility for Histopathology and Digital Pathology, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg Im Breisgau, Germany
| | - Martin Pichotka
- grid.5963.9Medical Physics, Department of Radiology, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany
| | - Fabian Bamberg
- grid.5963.9Department of Radiology, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany
| | - Marisa Windfuhr-Blum
- grid.5963.9Department of Radiology, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany
| | - Thalia Erbes
- grid.5963.9Department of Obstetrics and Gynecology, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany
| | - Jakob Neubauer
- grid.5963.9Department of Radiology, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany
| |
Collapse
|
2
|
Balamou C, Koïvogui A, Zysman K, Rodrigue CM, Rymzhanova R. Impact of tomosynthesis on the evolution of the cancer detection rate in the French National Breast Cancer Screening Program. Public Health 2022; 210:65-73. [PMID: 35870323 DOI: 10.1016/j.puhe.2022.06.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2021] [Revised: 05/09/2022] [Accepted: 06/13/2022] [Indexed: 11/27/2022]
Abstract
OBJECTIVES This study aims to evaluate the cancer detection rate in French National Breast Cancer Screening Program, especially the cancer detection rate during second reading session (Reading 2) based on digital technologies used in radiology centres. STUDY DESIGN This was an analytical and descriptive study. METHODS Cancer detection rate was estimated by the ratio between the number of cancers detected and the number of women screened. The positive predictive value (PPV) was estimated as cancer detection rate among abnormal Reading 2. The relationship between Reading 2's PPV and the predictive factors was evaluated using multilevel mixed-effects logistic regression. RESULTS A total of 1,380,006 digital mammograms were retained in the analysis between 2010 and 2019. Cancer detection rate represented 7.8‰ at first reading session (Reading 1) and 0.5‰ at Reading 2. Cancer detection rate is significantly associated with the use of tomosynthesis (P < 0.001) at Reading 1, and differences appear within different tomosynthesis brands (P = 0.007). Reading 2's PPV differs significantly according on technologies used by first Reader (P < 0.004). Nevertheless, Reading 2 has 1.9 (1.5-2.4) more likely to predict a cancer with the presence of previous mammogram compared with those without previous images. CONCLUSION Using tomosynthesis technology improves cancer detection rate at Reading 1, even if differences are noticeable between brands. Using tomosynthesis technology at Reading 1 reduces Reading 2's PPV and cancer detection rate at Reading 2.
Collapse
Affiliation(s)
- C Balamou
- Centre Régional de Coordination des Dépistages des Cancers en Auvergne-Rhône-Alpes, Site de L'Ain, 01000 Bourg-en-Bresse, France.
| | - A Koïvogui
- Centre Régional de Coordination des Dépistages des Cancers en Ile-de-France, Site de Seine-Saint-Denis, 93146 Bondy, France.
| | - K Zysman
- Centre Régional de Coordination des Dépistages des Cancers en Auvergne-Rhône-Alpes, Site de L'Isère, 38240 Meylan, France.
| | - C M Rodrigue
- Centre Régional de Coordination des Dépistages des Cancers en Auvergne-Rhône-Alpes, Site de L'Ain, 01000 Bourg-en-Bresse, France.
| | - R Rymzhanova
- Centre Régional de Coordination des Dépistages des Cancers en Bourgogne-Franche-Comté, Site Franche-Comté, 25000 Besançon, France
| |
Collapse
|